Litigation Details for UCB, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2019)

UCB, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2019)

Docket		Date Filed	2019-03-06
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Patents	10,130,589; 6,699,498; 6,884,434; 8,246,979; 8,246,980; 8,617,591; 9,925,150
Link to Docket	External link to docket

Details for UCB, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-09-16	135	Opinion - Memorandum Opinion	claims of U.S. Patent No. 10,130,589 (the "'589 Patent"), the patent asserted by the… regarding related patents, U.S. Patent Nos. 6,884,434 (the "'434 Patent") and 8,232,…quot;'414 Patent"), and held the '414 Patent invalid and the '434 Patent valid and … Book patents related to Neupro® to determine whether any of them were 'blocking patents[,]"…and fourth, UCB's other patents did not function as blocking patents. (D.I. 110 at 4-5.)	External link to document
2019-08-02	18	Notice of Service	Initial Infringement Contentions for U.S. Patent No. 10,130,589 B2 filed by LTS Lohmann Therapie-Systeme… 6 March 2019 1:19-cv-00474 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-04-07	196	Judgment	2, 3, 7, 10, 11, and 12 of U.S. Patent No. 10,130,589 (the '589 Patent) are invalid.. Signed by Judge …3, 7, 10, 11, and 12 of U.S. Patent No. 10,130,589 (the '589 Patent) are invalid. SO…for relief requested in Plaintiffs' Complaint for Patent Infringement D.I. 1 are denied with prejudice; …relief requested in Plaintiffs' Complaint for Patent Infringement (D.I. 1) are denied with prejudice… 6 March 2019 1:19-cv-00474 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document